Sugary drinks not only cause headaches but can give women cancer

December 4, 2013

Three out of four migraine sufferers may have reactive hypoglycemia, which may be contributing to their headaches. Reactive hypoglycemia is the so called sugar crash – a drop in blood glucose level after eating or drinking a large amount of sugar. The body’s reaction to the consumption of sugar is to produce insulin, but in those with reactive hypoglycemia too much insulin is produced and the blood sugar level drops below normal.

A recent study published in Cancer Epidemiology, Biomarkers & Prevention and reported in the NY Times showed that high consumption of sugary drinks significantly raises the risk of endometrial cancer. The researchers at the National Institutes of Health who conducted this large study speculated that the wide fluctuations in sugar levels from very high to very low could play a role in the development of cancer.

Obviously, there are other reasons to avoid sugary drinks, such as to avoid weight gain which leads to more frequent migraine and other health problems, such as diabetes, heart disease, strokes, and other. For that matter it is not just sugary drinks, but sugar in any form. Many of my patients are often surprised that I would even advise against drinking orange juice, eating grapes, melons, or other very sweet fruit. These fruit have some redeeming properties, such as having vitamins and fiber, but they also contain too much sugar and can cause the same problems as refined sugar.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe